With that many data points, patterns of broader health benefits are emerging beyond what clinical studies have been able to capture
In the landmark STEP 1 trial, a DXA body-composition substudy revealed that participants on semaglutide 2.4 mg lost an average of 9.7% of their lean body mass over 68 weeks
Use of glucagon-like peptide 1 agonists for weight loss compared with bupropion-naltrexone was associated with an increased risk for pancreatitis, gastroparesis and bowel obstruction but not biliary disease, researchers reported in JAMA
Nevertheless, when analyses were adjusted for BMI, level of physical activity, number of somatic comorbidities, smoking status and alcohol use, results were substantially unchanged
The medication typically helps regulate mood, improve sleep patterns, and energy levels while reducing the physical tension that accompanies anxious depression
It contains sodium hyaluronate, which provides deep hydration and keeps the skin plump and smooth all day long